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P ro s ta te (M S K C C 2 0 1 0 ) P ro s ta te (steps 1-4) . 1) Incubation with primary antibodies to your two proteins of interest according to antibodies optimized immunofluorescence staining procedure. Antibodies need to be of different species (e.g. rabbit and mouse) (Note: if probing for same protein in second PLA, a monoclonal antibody is needed). Keep in mind that due to variations in antibody binding, you may not detect all complexes. 2) Add in the secondary PLA antibodies that will target the different species, with one being PLUS labeled and the other being MINUS labeled. 3) Ligate the two PLA probes together using ligation buffer. 4) Using the amplification buffer, perform the rolling circle PCR (contains fluorescent dNTPs for visualization). 5) To maintain separate PLA reactions, spike in ddNTPs to terminate PCR in step 4. 6) Conjugate a PLUS and MINUS PLA probe to your next set of primary antibodies targeting your next two proteins of interest. Antibodies can be any species (Note: if probing for same protein in the first PLA reaction use a polyclonal at this step). 7) Repeat step 1 with optimized immunofluorescence staining procedure for your primary antibodies uesd in step 6. Due to variations in antibody binding and hindrances, you may not detect all complexes. Therefore, if you are probing the same protein from the first PLA, you may not pick up all the complexes from the first PLA reaction, or you may pick up one that was not detected in the first. Further, complex formation under treatment conditions may change binding and be informative with proper controls. 8) Skip step two and repeat ligation step 3. 9) Repeat step 4 only using a different color than previously. Afterwards you can mount and visualize.
Supplemental Experimental Procedures
Immunoblotting Primary antibodies used were: ATG7 (8558S), ATG5 (12994S), ULK1 (4773), Beclin-1 (3738) (Cell Signaling, Danvers, MA); LC3 (NB100-2220) (Novus Biologicals, Littleton, CO); p62 (Abnova, H00008878-M01); RIPK1 (BD Transduction Lab, 610459); RIPK3 (ProSci, 2283); MLKL (Millipore, MABC604); pMLKL (made in Doug R. Green's laboratory); LAMP2 (Abcam, ab37024-100); and Stx17 (HPA001204). Secondary anti-rabbit and anti-mouse antibodies (Cell Signaling, 7074 and 7076 respectively) were used at 1:5000 and imaged using ECL (Millipore, WBKLS0500) on an Odyssey (LiCor). Quantification of LC3II bands was done using Image Studio.
Dual Proximity Ligation Assay (dPLA)
In the dual PLA ( Figure S7 ), the first pair of ATG5 and RIPK1 was performed in red following manufacturer's directions, except at 15 minutes prior to end of the PCR reaction; ddNTPs were added at 1mM working concentration (Sigma, GE27-2045-01) . After which, slides were washed with Wash Buffer B and fixed again with 3.7% formaldehyde for 5 min. Slides were washed with 1xPBS and the second set of primary antibodies with conjugated PLA PLUS and MINUS probes (Sigma, DUO92009 and DUO92010, respectively) to polyclonal ATG5 and MLKL, respectively, and were incubated overnight. The second PLA in green (Sigma, DUO92014) was performed according to manufacturer's directions only instead starting at the ligation step, as the antibodies already contained the oligo probes, and then followed till the end. Slides were imaged blinded on a Zeiss epi-fluorescent microscope and a Minas spinning disk confocal. A total of at least 30 cells were quantified per treatment for puncta/cell by using Nikon NIS Elements software, thresholding for intensity. See Figure S7 .
shRNA infections TRC shRNAs used are as follows, TRC: Ripk1 (22468), Ripk3 (412795), Mlkl (360818), Atg7 (7587), Atg5 (99431), p62/Sqstm1 (238133), Beclin1 (87288), Ulk1 (28768, 28801,361568), FIP200 (304383, 304,384, 310918) , non-target (SHC016). siRNA for Rubicon (Dharmacon, L-041191-01-005) was done at a final concentration of 50 nM (total siRNA) using 0.2 μl lipofectamine 2000 (Invitrogen,11668027) in 20 μl Opti-MEM (Invitrogen, 31985-062) and 80 μl mouse prostate media. Level of targeted knockdown was determined by immunoblotting.
Flow Cytometry
Annexin V/PI Assay MPEC cells (both floxed and Cre deleted) were cultured at 2 x 10 5 in a 6-well and incubated overnight. Cells were exposed to either TRAIL, QVD, or Necrostatin-1for 24 hours. Using Annexin V-FITC Detection kit from BioTool (Houston, TX #B32117) cells were harvested and stained according to manufacturer's instructions. Flow data was acquired on a Gallios561 and analyzed using Summit v5.1 (Beckman Coulter, Fort Collins, CO).
Caspase 3/7 Assay MPEC cells (both floxed and Cre deleted) were cultured at 2 x 10 5 in a 6-well and incubated overnight. Cells were exposed to either TRAIL, QVD, or Necrostatin-1for 24 hours. Using CellEvent Caspase 3/7 Green Detection Reagent (Molecular Probes, # C10423) and Sytox Red Dead Cell Stain (Molecular Probes, # S34859) cells were harvested and stained according to manufacturer's instructions. Flow data was acquired on a Gallios561 and analyzed using Summit v5.1 (Beckman Coulter, Fort Collins, CO).
Reactive Oxygen Species (ROS)
MPEC cells (both floxed and Cre deleted) were cultured at 2 x 10 5 in a 6-well and incubated overnight. Cells were exposed to TRAIL and H2O2 as a positive control. Cells were harvested and ROS were stained for using CM-H2DCFDA (Molecular Probes, #C6827) following manufacturer's protocols. Flow data was acquired on a Gallios561 and analyzed using Kaluza (Beckman Coulter, Fort Collins, CO).
